The SEVEN-UP study [11, 12] reported that most eyes with age-related macular degeneration (AMD) require anti-VEGF treatment over a long period, and the constant neutralization of VEGF may cause RPE atrophy and choriocapillary atrophy threatening visual conditions. This evidence concerns the gene VEGFA and age-related macular degeneration.